Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001567619-19-009848
Filing Date
2019-05-06
Accepted
2019-05-06 16:00:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 64534
  Complete submission text file 0001567619-19-009848.txt   66395
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88577 | Film No.: 19799245
SIC: 2836 Biological Products, (No Diagnostic Substances)